Literature DB >> 18063449

Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge.

Fabiana Kömmling Seixas1, Everton Fagonde da Silva, Daiane Drawanz Hartwig, Gustavo Maia Cerqueira, Marta Amaral, Michel Quevedo Fagundes, Robson Grando Dossa, Odir Antônio Dellagostin.   

Abstract

The bacillus Calmette--Guerin (BCG), a live attenuated Mycobacterium bovis strain is considered a promising candidate as a vector system for delivery of foreign antigens to the immune system. The gene coding for the Leptospira interrogans external membrane protein LipL32, a highly immunogenic antigen found in all pathogenic leptospira, was cloned into several mycobacterial vectors for expression in BCG. Hamsters immunized with recombinant BCG (rBCG) expressing LipL32 were protected against mortality (P<or=0.05) upon challenge with a lethal inoculum of L. interrogans serovar Copenhageni. Autopsy examination did not reveal macroscopic or histological evidence of disease in rBCG immunized hamsters that survived lethal challenge. The data presented here further enhance the status of LipL32 as a promising candidate antigen for use in the control of leptospirosis, when presented to the immune system by an appropriate delivery system.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18063449     DOI: 10.1016/j.vaccine.2007.10.052

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  32 in total

1.  Calcium binding to leptospira outer membrane antigen LipL32 is not necessary for its interaction with plasma fibronectin, collagen type IV, and plasminogen.

Authors:  Pricila Hauk; Angela Silva Barbosa; Paulo Lee Ho; Chuck Shaker Farah
Journal:  J Biol Chem       Date:  2011-12-06       Impact factor: 5.157

2.  Subunit approach to evaluation of the immune protective potential of leptospiral antigens.

Authors:  Samuel R Félix; Daiane D Hartwig; Ana Paula C Argondizzo; Éverton F Silva; Fabiana K Seixas; Amilton C P Seixas Neto; Marco A Medeiros; Walter Lilenbaum; Odir A Dellagostin
Journal:  Clin Vaccine Immunol       Date:  2011-10-26

3.  Characterization of virulence of Leptospira isolates in a hamster model.

Authors:  Everton F Silva; Cleiton S Santos; Daniel A Athanazio; Núbia Seyffert; Fabiana K Seixas; Gustavo M Cerqueira; Michel Q Fagundes; Claudiomar S Brod; Mitermayer G Reis; Odir A Dellagostin; Albert I Ko
Journal:  Vaccine       Date:  2008-05-27       Impact factor: 3.641

Review 4.  Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen.

Authors:  Albert I Ko; Cyrille Goarant; Mathieu Picardeau
Journal:  Nat Rev Microbiol       Date:  2009-10       Impact factor: 60.633

5.  OmpL1 is an extracellular matrix- and plasminogen-interacting protein of Leptospira spp.

Authors:  Luis G V Fernandes; Monica L Vieira; Karin Kirchgatter; Ivy J Alves; Zenaide M de Morais; Silvio A Vasconcellos; Eliete C Romero; Ana L T O Nascimento
Journal:  Infect Immun       Date:  2012-07-16       Impact factor: 3.441

6.  The use of halloysite clay and carboxyl-functionalised multi-walled carbon nanotubes for recombinant LipL32 antigen delivery enhanced the IgG response.

Authors:  Daiane D Hartwig; Kátia L Bacelo; Thaís L Oliveira; Rodrigo Schuch; Fabiana K Seixas; Tiago Collares; Oscar Rodrigues; Cláudia P Hartleben; Odir A Dellagostin
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-01-23       Impact factor: 2.743

7.  Vaccination with leptospiral outer membrane lipoprotein LipL32 reduces kidney invasion of Leptospira interrogans serovar canicola in hamsters.

Authors:  P C Humphryes; M E Weeks; M AbuOun; G Thomson; A Núñez; N G Coldham
Journal:  Clin Vaccine Immunol       Date:  2014-02-12

8.  Recombinant Mycobacterium bovis BCG is a promising platform to develop vaccines against Trypansoma cruzi infection.

Authors:  I Bontempi; K Leal; E Prochetto; G Díaz; G Cabrera; A Bortolotti; H R Morbidoni; S Borsuk; O Dellagostin; I Marcipar
Journal:  Clin Exp Immunol       Date:  2020-07-06       Impact factor: 4.330

9.  Transcriptional responses of Leptospira interrogans to host innate immunity: significant changes in metabolism, oxygen tolerance, and outer membrane.

Authors:  Feng Xue; Haiyan Dong; Jinyu Wu; Zuowei Wu; Weilin Hu; Aihua Sun; Bryan Troxell; X Frank Yang; Jie Yan
Journal:  PLoS Negl Trop Dis       Date:  2010-10-26

10.  A conserved region of leptospiral immunoglobulin-like A and B proteins as a DNA vaccine elicits a prophylactic immune response against leptospirosis.

Authors:  Karine M Forster; Daiane D Hartwig; Fabiana K Seixas; Kátia L Bacelo; Marta Amaral; Cláudia P Hartleben; Odir A Dellagostin
Journal:  Clin Vaccine Immunol       Date:  2013-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.